STOCK TITAN

SLDB (NASDAQ: SLDB) holder plans 28,335-share stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of SLDB common stock has filed a notice of proposed sales under Rule 144. The filing covers 28,335 shares of common stock, to be sold through E*TRADE Financial Corporation on 02/02/2026 on the NASDAQ, with an aggregate market value of $182,389.56. These shares were acquired on the same date through settlement of performance share awards as compensation from the issuer. The filing reports that 82,561,235 shares of this class were outstanding, and indicates no other sales by this holder in the past three months.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for SLDB report?

The Form 144 reports a planned sale of 28,335 shares of SLDB common stock. The shares are to be sold on NASDAQ through E*TRADE Financial Corporation, with an aggregate market value of $182,389.56, as disclosed in the filing.

How many SLDB shares are planned to be sold and at what value?

The filing states that 28,335 SLDB common shares are planned for sale. The disclosed aggregate market value is $182,389.56, indicating the total market value of the shares covered by this specific Rule 144 notice at the time of the filing.

How were the SLDB shares in this Form 144 acquired?

According to the filing, the 28,335 SLDB shares were acquired on 02/02/2026 through settlement of performance shares. The nature of payment is listed as compensation, meaning the securities were received as part of an incentive or award arrangement.

On which exchange will the SLDB shares be sold under this Form 144?

The Form 144 specifies that the SLDB common stock covered by the notice is planned to be sold on the NASDAQ. The broker handling the transaction is listed as E*TRADE Financial Corporation, with its address provided in the filing details.

How many SLDB shares were outstanding when this Form 144 was filed?

The filing reports that 82,561,235 shares of SLDB common stock were outstanding. This figure provides context for the size of the planned 28,335-share sale relative to the total number of shares of this class in existence at that time.

Does the SLDB Form 144 show any other recent sales by this holder?

The section requesting information on securities sold during the past three months contains no disclosed transactions. This indicates that, in this Form 144, the holder did not report other SLDB sales in the three months preceding this notice.
Solid Bioscience

NASDAQ:SLDB

View SLDB Stock Overview

SLDB Rankings

SLDB Latest News

SLDB Latest SEC Filings

SLDB Stock Data

736.95M
65.05M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CHARLESTOWN